TREM2-mediated early microglial response limits diffusion and toxicity of amyloid plaques
Open accessThe DOI matches its Crossref record; 31 of the 32 references it cites were found in a registry or an index.
Abstract
Triggering receptor expressed on myeloid cells 2 (TREM2) is a microglial receptor that recognizes changes in the lipid microenvironment, which may occur during amyloid β (Aβ) accumulation and neuronal degeneration in Alzheimer’s disease (AD). Rare TREM2 variants that affect TREM2 function lead to an increased risk of developing AD. In murine models of AD, TREM2 deficiency prevents microglial clustering around Aβ deposits. However, the origin of myeloid cells surrounding amyloid and the impact of TREM2 on Aβ accumulation are a matter of debate. Using parabiosis, we found that amyloid-associated myeloid cells derive from brain-resident microglia rather than from recruitment of peripheral blood monocytes. To determine the impact of TREM2 deficiency on Aβ accumulation, we examined Aβ plaques in the 5XFAD model of AD at the onset of Aβ-related pathology. At this early time point, Aβ accumulation was similar in TREM2-deficient and -sufficient 5XFAD mice. However, in the absence of TREM2, Aβ plaques were not fully enclosed by microglia; they were more diffuse, less dense, and were associated with significantly greater neuritic damage. Thus, TREM2 protects from AD by enabling microglia to surround and alter Aβ plaque structure, thereby limiting neuritic damage.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“loss of TREM2 function in AD mouse models restricts the ability of microglia to surround Aβ plaques15,16, proliferate, and convert to DAM10,15,17, which in turn leads to more profound neuritic dystrophy18,19.”
From Human and mouse single-nucleus transcriptomics reveal TREM2-dependent and TREM2-independent cellular responses in Alzheimer’s disease (2020) · cites this paper as [19]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“which may represent dystrophic neurons that accumulate over time as a result of ineffective microglial control of AD pathology due to lack of Trem218,19.”
From Human and mouse single-nucleus transcriptomics reveal TREM2-dependent and TREM2-independent cellular responses in Alzheimer’s disease (2020) · cites this paper as [19]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“the compaction of protofibrillary Aβ into a dense core plaque, which requires apoE and is promoted by TREM2 (Bales et al., 1997b, 1999; Bien-Ly et al., 2012; Wang et al., 2016; Yuan et al., 2016), could be a protective mechanism that limits neurotoxicity of amyloid deposits once they start to build up in the aging brain.”
From Microglia in Alzheimer’s disease (2018) · cites this paper as Wang et al., 2016
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Trem2 deficiency induces dynamic changes but an eventual increase in plaque and neuritic pathology (Jay et al., 2017; Wang et al., 2015; Wang et al., 2016; Yuan et al., 2016).”
From Elevated TREM2 Gene Dosage Reprograms Microglia Responsivity and Ameliorates Pathological Phenotypes in Alzheimer’s Disease Models (2018) · cites this paper as Wang et al., 2016
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Lack of TREM2 results in impaired plaque trimming, which leads to enlarged plaques with reduced compaction48,49.”
From Interplay between innate immunity and Alzheimer disease: APOE and TREM2 in the spotlight (2018) · cites this paper as [48]
Experimental — accuracy not yet measured
42 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Oakley, H., Cole, S. L., Logan, S., Maus, E., Shao, P., Craft, J., Guillozet-Bongaarts, A., Ohno, M., Disterhoft, J., Van Eldik, L., et al. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.1202-06.2006 · Cited by 3,530
NLRP3 is activated in Alzheimer’s disease and contributes to pathology in APP/PS1 mice
Heneka, M. T., Kummer, M. P., Stutz, A., Delekate, A., Schwartz, S., Vieira-Saecker, A., Griep, A., Axt, D., Remus, A., Tzeng, T.-C., et al. (2013) · Nature · doi:10.1038/nature11729 · Cited by 2,898 · cited 4×
“Brains were isolated 3 h after injection and made into single-cell suspension as previously described (Heneka et al., 2013).”
BackgroundMethodInfluentialIdentification of a unique TGF-β–dependent molecular and functional signature in microglia
Butovsky, O., Jedrychowski, M. P., Moore, C. S., Cialic, R., Lanser, A. J., Gabriely, G., Koeglsperger, T., Dake, B., Wu, P. M., Doykan, C. E., et al. (2014) · Nature Neuroscience · doi:10.1038/nn.3599 · Cited by 2,543 · cited 1×
“However, phenotypic markers of migroglia, such as low expression of CD45 and high expression of the P2Y(12) receptor, are altered upon microglial activation and therefore do not precisely discriminate microglia from monocytes (Butovsky et al., 2014).”
BackgroundTREM2 Lipid Sensing Sustains the Microglial Response in an Alzheimer’s Disease Model
Wang, Y., Cella, M., Mallinson, K., Ulrich, J. D., Young, K. L., Robinette, M. L., Gilfillan, S., Krishnan, G. M., Sudhakar, S., Zinselmeyer, B. H., et al. (2015) · Cell · doi:10.1016/j.cell.2015.01.049 · Cited by 1,736 · cited 11×
“…response to Aβ deposits in all AD models, changes in Aβ burden develop more slowly; therefore, the discrepancies in Aβ accumulation may be a result of the varied timing of the analyses—8 mo in 5XFAD mice (Wang et al., 2015) and 3–4 mo in APP PS1-21 mice (Ulrich et al., 2014; Jay et al., 2015).”
BackgroundMethodResultInfluentialSelf-citationAlzheimer’s Disease: The Challenge of the Second Century
Holtzman, D. M., Morris, J. C., & Goate, A. M. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002369 · Cited by 1,424 · cited 1×
“Key pathological features of AD consist of the deposition of amyloid-β peptide (Aβ) and hyperphosphorylated tau aggregates that, together, are linked with synapse loss and neuronal cell death, as well as activation of microglia and astrocytes (Holtzman et al., 2011).”
BackgroundSelf-citationAlzheimer’s Disease Risk Genes and Mechanisms of Disease Pathogenesis
Karch, C. M., & Goate, A. M. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.05.006 · Cited by 1,357 · cited 1×
“Recent genome-wide association studies have identified rare variants of genes that encode immune receptors as risk factors (Guerreiro and Hardy, 2014; Karch and Goate, 2015).”
BackgroundMicroglia and brain macrophages in the molecular age: from origin to neuropsychiatric disease
Prinz, M., & Priller, J. (2014) · Nature Reviews Neuroscience · doi:10.1038/nrn3722 · Cited by 1,329 · cited 1×
“Given that brain-resident microglia are capable of self-renewal and expansion (Gomez Perdiguero et al., 2013; Greter and Merad, 2013; Prinz and Priller, 2014), we next sought to determine if microglia associated with plaques resulted from the proliferation of resident microglia.”
BackgroundTakahashi, K., Rochford, C. D. P., & Neumann, H. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041611 · Cited by 1,124 · cited 2×
“TREM2 signaling promotes survival, proliferation, phagocytosis, and secretion of cytokines and chemokines (Takahashi et al., 2005; Otero et al., 2009; Wang et al., 2015).”
BackgroundThe Genetics of Alzheimer's Disease
Bertram, L., & Tanzi, R. E. (2012) · Progress in Molecular Biology and Translational Science · doi:10.1016/b978-0-12-385883-2.00008-4 · Cited by 760
The genetics of Alzheimer disease
Tanzi, R. E. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006296 · Cited by 727 · cited 2×
“The origin of nonfamilial AD is less well understood and may depend on a combination of genetic and nongenetic risk factors (Tanzi, 2012).”
Background
Cited by
Items 201–300 of 838
Hernandez, M. X., Jiang, S., Cole, T. A., Chu, S.-H., Fonseca, M. I., Fang, M. J., Hohsfield, L. A., Torres, M. D., Green, K. N., Wetsel, R. A., et al. (2017) · Molecular Neurodegeneration · doi:10.1186/s13024-017-0210-z · Cited by 105
“Recent data suggest TREM2 is important in microgliosis and containment of Aß plaques over the progression of the disease [66, 67].”
BackgroundPlescher, M., Seifert, G., Hansen, J. N., Bedner, P., Steinhäuser, C., & Halle, A. (2018) · Glia · doi:10.1002/glia.23318 · Cited by 100
“…regions, which in addition to lipids and Ab oligomer species contains pro- and anti-inflammatory cytokines (Armstrong, Lantos, & Cairns, 2008; Heneka et al., 2015; Kiskis et al., 2015; Wang et al., 2015; Wang et al., 2016), obviously affect microglial ion channel expression patterns.”
BackgroundInfluentialSoluble TREM2 and biomarkers of central and peripheral inflammation in neurodegenerative disease
Bekris, L. M., Khrestian, M., Dyne, E., Shao, Y., Pillai, J. A., Rao, S. M., Bemiller, S. M., Lamb, B., Fernandez, H. H., & Leverenz, J. B. (2018) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2018.03.003 · Cited by 99
The A1 astrocyte paradigm: New avenues for pharmacological intervention in neurodegeneration
Hinkle, J. T., Dawson, V. L., & Dawson, T. M. (2019) · Movement Disorders · doi:10.1002/mds.27718 · Cited by 99
“Microglia trim extracellular filamentous β-amyloid in a TREM2-dependent manner; this process compacts it into plaques, which blocks its spread and enables formation of barriers to reduce its local neurotoxicity.(28,29) Finally, TREM2 appears to regulate adoption of the DAM transcriptional signature, given that the app…”
BackgroundMedrano-Jiménez, E., Jiménez-Ferrer Carrillo, I., Pedraza-Escalona, M., Ramírez-Serrano, C. E., Álvarez-Arellano, L., Cortés-Mendoza, J., Herrera-Ruiz, M., Jiménez-Ferrer, E., Zamilpa, A., Tortoriello, J., et al. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1515-3 · Cited by 98
A neurodegenerative cellular stress response linked to dark microglia and toxic lipid secretion
Flury, A. G., Aljayousi, L., Park, H.-J., Khakpour, M., Mechler, J., Aziz, S., McGrath, J. D., Deme, P., Sandberg, C., Ibáñez, F. G., et al. (2024) · Neuron · doi:10.1016/j.neuron.2024.11.018 · Cited by 111
Microglia responses to interleukin‐6 and type I interferons in neuroinflammatory disease
West, P. K., Viengkhou, B., Campbell, I. L., & Hofer, M. J. (2019) · Glia · doi:10.1002/glia.23634 · Cited by 98
“gering receptor expressed in myeloid cells 2 (Trem2; Wang et al., 2016; Yuan et al., 2016), microglial barrier formation around plaques is impaired, resulting in extended, diffuse plaques and exaggerated neu-”
BackgroundSoluble TREM2 is elevated in Parkinson’s disease subgroups with increased CSF tau
Wilson, E. N., Swarovski, M. S., Linortner, P., Shahid, M., Zuckerman, A. J., Wang, Q., Channappa, D., Minhas, P. S., Mhatre, S. D., Plowey, E. D., et al. (2020) · Brain · doi:10.1093/brain/awaa021 · Cited by 99
“…in microglia is supported by genome-wide association studies (Guerreiro et al. , 2013; Jonsson et al. , 2013) and preclinical research in mouse models of Alzheimer’s disease (Wang et al. , 2016; Raha et al. , 2017; Ulland et al. , 2017; Cheng-Hathaway et al. , 2018; Parhizkar et al. , 2019).”
BackgroundMicroglia and astrocyte involvement in neurodegeneration and brain cancer
Vandenbark, A. A., Offner, H., Matejuk, S., & Matejuk, A. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02355-0 · Cited by 108
TREM2 is required for microglial instruction of astrocytic synaptic engulfment in neurodevelopment
Jay, T. R., von Saucken, V. E., Muñoz, B., Codocedo, J. F., Atwood, B. K., Lamb, B. T., & Landreth, G. E. (2019) · Glia · doi:10.1002/glia.23664 · Cited by 97
“, 2016), phagocytose Aβ (Jay et al., 2017; Jiang et al., 2014; Kleinberger et al., 2014; Melchior et al., 2010; Parhizkar et al., 2019; Wang et al., 2016; Yuan et al., 2016) and engage in Aβ-driven phenotypic changes in mouse models of AD (Jay et al.”
BackgroundTerzioglu, G., & Young-Pearse, T. L. (2023) · Molecular Neurodegeneration · doi:10.1186/s13024-023-00674-9 · Cited by 91
“Moreover, in AD mouse models, the number of microglia per plaque was reduced when Trem2 or Axl are knocked out, whereas loss of one or both copies of Inpp5d increased the number of microglia that surround plaques [136, 153, 163, 164].”
BackgroundYan, P., Kim, K.-W., Xiao, Q., Ma, X., Czerniewski, L. R., Liu, H., Rawnsley, D. R., Yan, Y., Randolph, G. J., Epelman, S., et al. (2022) · Journal of Clinical Investigation · doi:10.1172/jci152565 · Cited by 95
“Recent attempts to avoid these experimental pitfalls through a parabiosis approach did not demonstrate recruitment of peripheral monocytes; however, these studies were limited to a short 4-week observation window (19).”
TREM2 in Alzheimer’s Disease: Microglial Survival and Energy Metabolism
Zheng, H., Cheng, B., Li, Y., Li, X., Chen, X., & Zhang, Y.-W. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00395 · Cited by 94
“…findings have offered key insight into the role of TREM2 in Aβ pathologies, in which TREM2 strongly affects the ability of microglia to respond Frontiers in Aging Neuroscience | www.frontiersin.org 3 November 2018 | Volume 10 | Article 395 to plaques (Colonna and Wang, 2016; Udeochu et al., 2018).”
BackgroundInfluentialThomas, A. L., Lehn, M. A., Janssen, E. M., Hildeman, D. A., & Chougnet, C. A. (2022) · Scientific Reports · doi:10.1038/s41598-022-21920-y · Cited by 94
Socodato, R., Portugal, C. C., Canedo, T., Rodrigues, A., Almeida, T. O., Henriques, J. F., Vaz, S. H., Magalhães, J., Silva, C. M., Baptista, F. I., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.107796 · Cited by 94
Moutinho, M., Puntambekar, S. S., Tsai, A. P., Coronel, I., Lin, P. B., Casali, B. T., Martinez, P., Oblak, A. L., Lasagna-Reeves, C. A., Lamb, B. T., et al. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abl7634 · Cited by 92
Taylor, X., Cisternas, P., You, Y., You, Y., Xiang, S., Marambio, Y., Zhang, J., Vidal, R., & Lasagna-Reeves, C. A. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-01900-7 · Cited by 91
Reifschneider, A., Robinson, S., van Lengerich, B., Gnörich, J., Logan, T., Heindl, S., Vogt, M. A., Weidinger, E., Riedl, L., Wind, K., et al. (2022) · The EMBO Journal · doi:10.15252/embj.2021109108 · Cited by 89
“…where they exhibit a protective function by encapsulating the protein deposits via a barrier function (Yuan et al , 2016) that promotes amyloid plaque compaction (Ulrich et al , 2014; Wang et al , 2016; Meilandt et al , 2020) and reduces de novo seeding of amyloid plaques (Parhizkar et al , 2019).”
The informed road map to prevention of Alzheimer Disease: a call to arms
McDade, E., Llibre-Guerra, J. J., Holtzman, D. M., Morris, J. C., & Bateman, R. J. (2021) · Molecular Neurodegeneration · doi:10.1186/s13024-021-00467-y · Cited by 89
Self-citationCarling, G. K., Fan, L., Foxe, N. R., Norman, K., Wong, M. Y., Zhu, D., Corona, C., Razzoli, A., Yu, F., Yarahmady, A., et al. (2024) · Neuron · doi:10.1016/j.neuron.2024.09.006 · Cited by 89
“43,51,54 We previously found that the R47H risk variant increases microglial DAM induction and exacerbates APOE upregulation in the P301S tauopathy model, pointing to interplay between these two strong genetic risk factors in microglia.”
Self-citationTREM2‐dependent effects on microglia in Alzheimer's disease
Zhou, Y., Ulland, T. K., & Colonna, M. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00202 · Cited by 82
“TREM2 is an immunoglobin (Ig) superfamily receptor present on various cells of the myeloid lineage including CNS microglia, bone osteoclasts, alveolar and peritoneal macrophages (Colonna and Wang, 2016).”
BackgroundSelf-citationStep by step: towards a better understanding of the genetic architecture of Alzheimer’s disease
Lambert, J.-C., Ramirez, A., Grenier-Boley, B., & Bellenguez, C. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-02076-1 · Cited by 87
“Many researchers have sought to link microglia, genetic risk factors (mainly TREM2 ) and A β peptides together through their impact on amyloid plaque formation/compaction [99 – 101], toxicity, and synapse pruning [102].”
BackgroundJackson, R. J., Keiser, M. S., Meltzer, J. C., Fykstra, D. P., Dierksmeier, S. E., Hajizadeh, S., Kreuzer, J., Morris, R., Melloni, A., Nakajima, T., et al. (2024) · Molecular Therapy · doi:10.1016/j.ymthe.2024.03.024 · Cited by 86
Self-citationFriend, Foe or Both? Immune Activity in Alzheimer’s Disease
Frost, G. R., Jonas, L. A., & Li, Y.-M. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00337 · Cited by 87
“…the development of the glial barrier often begins with the proliferation of reactive astrocytes near the damaged tissue, and the subsequent orchestration of astrocytes, oligodendrocyte precursor cells and microglia to build a rigid wall surrounding damage (Sofroniew, 2009; Wanner et al., 2013).”
BackgroundDynamic changes of CSF sTREM2 in preclinical Alzheimer’s disease: the CABLE study
Ma, L.-Z., Tan, L., Bi, Y.-L., Shen, X.-N., Xu, W., Ma, Y.-H., Li, H.-Q., Dong, Q., & Yu, J.-T. (2020) · Molecular Neurodegeneration · doi:10.1186/s13024-020-00374-8 · Cited by 84
“One explanation is that microglia initially form a barrier around the plaque, and sTREM2 released by microglia remains in the plaque until the barrier fails, followed by neural injury [33, 34].”
BackgroundImmune checkpoint TIM-3 regulates microglia and Alzheimer’s disease
Kimura, K., Subramanian, A., Yin, Z., Khalilnezhad, A., Wu, Y., He, D., Dixon, K. O., Chitta, U. K., Ding, X., Adhikari, N., et al. (2025) · Nature · doi:10.1038/s41586-025-08852-z · Cited by 85
Ocañas, S. R., Pham, K. D., Cox, J. E. J., Keck, A. W., Ko, S., Ampadu, F. A., Porter, H. L., Ansere, V. A., Kulpa, A., Kellogg, C. M., et al. (2023) · Journal of Neuroinflammation · doi:10.1186/s12974-023-02870-2 · Cited by 86
“TREM2 deficiency in mice prevented microglial clustering around amyloid beta plaques in the 5XFAD model [81] and prevented microglial transition to the Stage 2 DAM phenotype [21] and concomitant upregulation of Cst7 , Lpl , Csf1 , and Itgax (all identified as sex divergences in the pre-sent study).”
BackgroundShifting paradigms: The central role of microglia in Alzheimer’s disease
Schwabe, T., Srinivasan, K., & Rhinn, H. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.104962 · Cited by 84
Kaya, I., Jennische, E., Lange, S., Tarik Baykal, A., Malmberg, P., & Fletcher, J. S. (2020) · Journal of Neurochemistry · doi:10.1111/jnc.14999 · Cited by 82
“TREM2 lipid sensing was shown to sustain microglial response and metabolic fitness around the amyloid plaques and limits the diffusion and toxicity of amyloid plaques (Wang et al., 2016) in 5xFAD mice brain.”
BackgroundVilalta, A., Zhou, Y., Sevalle, J., Griffin, J. K., Satoh, K., Allendorf, D. H., De, S., Puigdellívol, M., Bruzas, A., Burguillos, M. A., et al. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.100631 · Cited by 77
Initiative, F. T. A. D. N., Takahashi, H., Klein, Z. A., Bhagat, S. M., Kaufman, A. C., Kostylev, M. A., Ikezu, T., & Strittmatter, S. M. (2017) · Acta Neuropathologica · doi:10.1007/s00401-017-1668-z · Cited by 83
“Importantly, recent studies have shown that microglia and TREM2/TYROBP play a critical role in reducing the diffuse Aβ deposition associated with already formed Aβ plaques and in reducing axonal dystrophy [15, 77, 83].”
Greve, H. J., Dunbar, A. L., Lombo, C. G., Ahmed, C., Thang, M., Messenger, E. J., Mumaw, C. L., Johnson, J. A., Kodavanti, U. P., Oblak, A. L., et al. (2023) · Brain · doi:10.1093/brain/awac113 · Cited by 82
Pereira, J. B., Janelidze, S., Strandberg, O., Whelan, C. D., Zetterberg, H., Blennow, K., Palmqvist, S., Stomrud, E., Mattsson-Carlgren, N., & Hansson, O. (2022) · Nature Aging · doi:10.1038/s43587-022-00310-z · Cited by 83
Sheng, L., Chen, M., Cai, K., Song, Y., Yu, D., Zhang, H., & Xu, G. (2019) · The FASEB Journal · doi:10.1096/fj.201900527r · Cited by 79
“As we all know, the amyloid accumulation resulted from the imbalance of amyloid producing and amyloid clearance (29).”
BackgroundMicroglia transcriptional states and their functional significance: Context drives diversity
Depp, C., Doman, J. L., Hingerl, M., Xia, J., & Stevens, B. (2025) · Immunity · doi:10.1016/j.immuni.2025.04.009 · Cited by 100
Targeting neuroinflammation in Alzheimer’s disease: evidence for NSAIDs and novel therapeutics
Deardorff, W. J., & Grossberg, G. T. (2017) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2016.1200972 · Cited by 81
Benitez, D. P., Jiang, S., Wood, J., Wang, R., Hall, C. M., Peerboom, C., Wong, N., Stringer, K. M., Vitanova, K. S., Smith, V. C., et al. (2021) · Molecular Neurodegeneration · doi:10.1186/s13024-021-00457-0 · Cited by 78
“Alternative roles for microglia in Aβ handling have been proposed, including compacting Aβ via TREM2dependent mechanisms [57, 58] or clearing Αβ via non-phagocytic mechanisms [summarised in 52].”
BackgroundMicroglial diversity in neuropathic pain
Tsuda, M., Masuda, T., & Kohno, K. (2023) · Trends in Neurosciences · doi:10.1016/j.tins.2023.05.001 · Cited by 85
Puntambekar, S. S., Saber, M., Lamb, B. T., & Kokiko-Cochran, O. N. (2018) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2018.03.033 · Cited by 76
“Furthermore, TREM2 signaling is critical for myeloid cell survival and proliferation in the AD brain, and reduces plaque-associated neurotoxicity by regulating compaction of toxic Aβ deposits (35,42) .”
BackgroundAnwar, S., & Rivest, S. (2020) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2020.1738391 · Cited by 77
“The inability of microglia to cluster around plaques without TREM2 was associated with defects in plaque compaction, microglia proliferation, and increased levels of dystrophic neurons [74,80,81].”
BackgroundAcute Trem2 reduction triggers increased microglial phagocytosis, slowing amyloid deposition in mice
Schoch, K. M., Ezerskiy, L. A., Morhaus, M. M., Bannon, R. N., Sauerbeck, A. D., Shabsovich, M., Jafar-nejad, P., Rigo, F., & Miller, T. M. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2100356118 · Cited by 78
“Genetic loss of Trem2 in Aβ-depositing mice reduces microglial clustering around amyloid plaques (13–17), which may permit an increase in plaque load or pathogenesis (18, 42).”
BackgroundTREM2 and sTREM2 in Alzheimer’s disease: from mechanisms to therapies
Zhang, L., Xiang, X., Li, Y., Bu, G., & Chen, X. (2025) · Molecular Neurodegeneration · doi:10.1186/s13024-025-00834-z · Cited by 97
“Studies in amyloid mouse models have demonstrated that the loss of functional TREM2 impairs microglial clustering around amyloid plaques, reducing microglial phagocytic capacity and leading to inefficient amyloid clearance [49, 83].”
Hashemiaghdam, A., & Mroczek, M. (2020) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2020.577185 · Cited by 81
Welcome, M. O. (2019) · NeuroMolecular Medicine · doi:10.1007/s12017-019-08547-5 · Cited by 80
Lee, S.-H., Rezzonico, M. G., Friedman, B. A., Huntley, M. H., Meilandt, W. J., Pandey, S., Chen, Y.-J. J., Easton, A., Modrusan, Z., Hansen, D. V., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.110158 · Cited by 78
Neuron Loss in Alzheimer’s Disease: Translation in Transgenic Mouse Models
Wirths, O., & Zampar, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21218144 · Cited by 75
“In APP transgenic mice, Aβ plaques in Trem2-deficient 5XFAD mice were more diffuse and associated with more neuritic damage [147]; however, information on overt neurodegeneration is currently lacking.”
BackgroundDanger-Sensing/Patten Recognition Receptors and Neuroinflammation in Alzheimer’s Disease
Chiarini, A., Armato, U., Hu, P., & Prà, I. D. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21239036 · Cited by 81
“Consequently, TREM2 knockout microglia does not enfold and compact Aβ plaques and does not form an isolating barrier preventing the plaques branching diffusion, the Aβ subspecies plaque content alteration, and the Aβ-related damage to dystrophic axons and dendrites, synaptic connections, and neurons in AD’s early stag…”
BackgroundFruhwürth, S., Zetterberg, H., & Paludan, S. R. (2024) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2024.578342 · Cited by 74
“In later stages of pathology, however, TREM2 signaling has been shown to promote A β deposition into established plaque structures (Wang et al., 2016; Mei-landt et al., 2020).”
Current views on meningeal lymphatics and immunity in aging and Alzheimer’s disease
Rego, S., Sánchez, G., & Mesquita, S. D. (2023) · Molecular Neurodegeneration · doi:10.1186/s13024-023-00645-0 · Cited by 82
“There is some consensus, however, regarding the beneficial role of recruited CCR2 + monocytes and brain PVMs in clearing vascular Aβ, despite their apparent lack of interaction with parenchymal Aβ plaques [161, 163, 175–178].”
BackgroundAmeliMojarad, M., & AmeliMojarad, M. (2024) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14856 · Cited by 73
“40 Mutations in microglia-related genes have a substantial impact on the ability of microglia, causing them to become permanently activated, reducing their capacity for phagocytosis, and ultimately resulting in neuroinflammation and neurodegeneration.”
BackgroundInfluentialElder, G. A., Ehrlich, M. E., & Gandy, S. (2019) · Neuroscience Letters · doi:10.1016/j.neulet.2019.134294 · Cited by 82
Plaque-associated myeloid cells derive from resident microglia in an Alzheimer's disease model
Reed-Geaghan, E. G., Croxford, A. L., Becher, B., & Landreth, G. E. (2020) · Journal of Experimental Medicine · doi:10.1084/jem.20191374 · Cited by 72
Melchiorri, D., Merlo, S., Micallef, B., Borg, J.-J., & Dráfi, F. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1196413 · Cited by 70
“This defective microglial response resulted in larger neuritic dystrophy and synaptic disconnection adjacent to Aβ plaque in AD early stages (Wang et al., 2016; Ulland et al., 2017).”
BackgroundTargeting Microglia in Alzheimer’s Disease: Pathogenesis and Potential Therapeutic Strategies
Sun, Z., Zhang, X., So, K.-F., Jiang, W., & Chiu, K. (2024) · Biomolecules · doi:10.3390/biom14070833 · Cited by 71
“…deletion or expression of the TREM2 R47H variant prevents microglial clustering around A β plaques, attenuates microgliosis, and facilitates A β and tau seeding and spreading near neuritic plaques, underscoring the key role of TREM2 and microglia in limiting peri-plaque tau pathologies [65–67].”
BackgroundLiu, H., Jin, M., Ji, M., Zhang, W., Liu, A., & Wang, T. (2022) · Aging · doi:10.18632/aging.203989 · Cited by 77
“TREM2 is one of the most highly expressed receptors in microglia (ranking 31st) and is >300-fold enriched in microglia compared to other cell types [33].”
BackgroundGedam, M., Comerota, M. M., Propson, N. E., Chen, T., Jin, F., Wang, M. C., & Zheng, H. (2023) · Journal of Clinical Investigation · doi:10.1172/jci167501 · Cited by 76
“These phenotypes are reminiscent of TREM2 deficiency (47–49), indicating a possible interaction between HIF-1 α and TREM2.”
Dysregulated Wnt Signalling in the Alzheimer’s Brain
Aghaizu, N. D., Jin, H., & Whiting, P. J. (2020) · Brain Sciences · doi:10.3390/brainsci10120902 · Cited by 70
“Three further Trem2-regulated genes—Wif1, Ctnna3 and Dkk2—can be categorised as negative regulators of Wnt signalling (note that Dkk2 can be a context-dependent activator and inhibitor of canonical Wnt signalling [47]) and their biological function in this context is most likely related to negative feedback [209].”
ResultInfluentialLoss of TREM2 Confers Resilience to Synaptic and Cognitive Impairment in Aged Mice
Qu, W., & Li, L. (2020) · The Journal of Neuroscience · doi:10.1523/jneurosci.2193-20.2020 · Cited by 72
“In AD, complete loss of TREM2 has been shown to affect Ab seeding at early stages but facilitate plaque compaction to limit the spread of Ab later (Jay et al., 2015, 2017; Wang et al., 2015, 2016).”
BackgroundBłaszczyk, J. W. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms24010543 · Cited by 86
Gut Metabolites Acting on the Gut-Brain Axis: Regulating the Functional State of Microglia
Deng, W., Yi, P., Xiong, Y., Ying, J., Lin, Y., Dong, Y., Wei, G., Wang, X., & Hua, F. (2023) · Aging and Disease · doi:10.14336/ad.2023.0727 · Cited by 72
“TREM2 protects against AD by enabling microglia to surround and alter Aβ plaque structures, thereby limiting neurite damage [140].”
BackgroundTrem2 deficiency differentially affects phenotype and transcriptome of human APOE3 and APOE4 mice
Fitz, N. F., Wolfe, C. M., Playso, B. E., Biedrzycki, R. J., Lu, Y., Nam, K. N., Lefterov, I., & Koldamova, R. (2020) · Molecular Neurodegeneration · doi:10.1186/s13024-020-00394-4 · Cited by 68
“We identified significant differences in the ratio of compact plaques to the protofibular halo amyloid staining, indicating a Trem2 mediated effect on plaque compaction in agreement with previous reports [9, 23].”
ResultLodder, C., Scheyltjens, I., Stancu, I. C., Botella Lucena, P., Gutiérrez de Ravé, M., Vanherle, S., Vanmierlo, T., Cremers, N., Vanrusselt, H., Brône, B., et al. (2021) · Acta Neuropathologica Communications · doi:10.1186/s40478-021-01204-8 · Cited by 71
Modulation of Glial Function in Health, Aging, and Neurodegenerative Disease
Hanslik, K., Marino, K. M., & Ulland, T. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.718324 · Cited by 56
Self-citationBelsare, K. D., Wu, H., Mondal, D., Bond, A., Castillo, E., Jin, J., Jo, H., Roush, A. E., Pilla, K. B., Sali, A., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2114486119 · Cited by 68
Wahane, S., Zhou, X., Zhou, X., Guo, L., Friedl, M.-S., Kluge, M., Ramakrishnan, A., Shen, L., Friedel, C. C., Zhang, B., et al. (2021) · Science Advances · doi:10.1126/sciadv.abd8811 · Cited by 67
Modulation of β-Amyloid Fibril Formation in Alzheimer’s Disease by Microglia and Infection
Brown, M. R., Radford, S. E., & Hewitt, E. W. (2020) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2020.609073 · Cited by 67
“In AD model mice, the deletion of TREM2 did not significantly affect Aβ deposition, but it did reduce the extent to which microglia surrounded Aβ plaques (Ulrich et al., 2014; Wang et al., 2016).”
BackgroundTesi, N., van der Lee, S. J., Hulsman, M., Jansen, I. E., Stringa, N., van Schoor, N. M., Scheltens, P., van der Flier, W. M., Huisman, M., Reinders, M. J. T., et al. (2020) · Translational Psychiatry · doi:10.1038/s41398-020-01018-7 · Cited by 67
Contribution of Gut Microbiota to Immunological Changes in Alzheimer’s Disease
van Olst, L., Roks, S. J. M., Kamermans, A., Verhaar, B. J. H., van der Geest, A. M., Muller, M., van der Flier, W. M., & de Vries, H. E. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.683068 · Cited by 74
Delizannis, A. T., Nonneman, A., Tsering, W., De Bondt, A., Van den Wyngaert, I., Zhang, B., Meymand, E., Olufemi, M. F., Koivula, P., Maimaiti, S., et al. (2021) · Acta Neuropathologica Communications · doi:10.1186/s40478-021-01251-1 · Cited by 65
The subfornical organ is a nucleus for gut-derived T cells that regulate behaviour
Yoshida, T. M., Nguyen, M. T., Zhang, L., Lu, B. Y., Zhu, B., Murray, K. N., Mineur, Y. S., Zhang, C., Xu, D., Lin, E., et al. (2025) · Nature · doi:10.1038/s41586-025-09050-7 · Cited by 76
Self-citationTakata, K., Amamiya, T., Mizoguchi, H., Kawanishi, S., Kuroda, E., Kitamura, R., Ito, A., Saito, Y., Tawa, M., Nagasawa, T., et al. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2017.10.021 · Cited by 72
Impaired αVβ8 and TGFβ signaling lead to microglial dysmaturation and neuromotor dysfunction
Arnold, T. D., Lizama, C. O., Cautivo, K. M., Santander, N., Lin, L., Qiu, H., Huang, E. J., Liu, C., Mukouyama, Y.-S., Reichardt, L. F., et al. (2019) · Journal of Experimental Medicine · doi:10.1084/jem.20181290 · Cited by 67
Brendel, M., Kleinberger, G., Probst, F., Jaworska, A., Overhoff, F., Blume, T., Albert, N. L., Carlsen, J., Lindner, S., Gildehaus, F. J., et al. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00008 · Cited by 66
“Besides facilitating therapeutic advances, the advantage of longitudinal assessments is also highlighted by a recent study hypothesizing that different timing of analyses accounts for discrepant findings of the effects of TREM2 deficiency on Aβ accumulation (Wang et al., 2016).”
BackgroundMuñoz-Castro, C., Mejias-Ortega, M., Sanchez-Mejias, E., Navarro, V., Trujillo-Estrada, L., Jimenez, S., Garcia-Leon, J. A., Fernandez-Valenzuela, J. J., Sanchez-Mico, M. V., Romero-Molina, C., et al. (2023) · Acta Neuropathologica Communications · doi:10.1186/s40478-023-01530-z · Cited by 66
“In fact, in the presence of Abeta accumulation, mutations or total ablation of TREM2 abolish both microglial migration and activation of the DAM phenotype [24, 60].”
BackgroundResultPsychedelic‐inspired approaches for treating neurodegenerative disorders
Saeger, H. N., & Olson, D. E. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15544 · Cited by 74
Wang, C., Nambiar, A., Strickland, M. R., Lee, C., Parhizkar, S., Moore, A., Musiek, E. S., Ulrich, J. D., & Holtzman, D. M. (2023) · Journal of Clinical Investigation · doi:10.1172/jci169131 · Cited by 74
“In addition to increased Aβ plaque deposition, previous studies suggested the idea that microglia restrict the formation of peri-plaque neuritic dystrophy (25, 39-41).”
Self-citationMagno, L., Bunney, T. D., Mead, E., Svensson, F., & Bictash, M. N. (2021) · Molecular Neurodegeneration · doi:10.1186/s13024-021-00436-5 · Cited by 64
“microglia from a homeostatic to a disease activated state [14, 15], which potentially confers neuroprotection by enhancing microglial function, including an upregulation of genes implicated in migration [16], phagocytosis [17], survival [18] and lipid metabolism [19].”
BackgroundMicroglial Function and Regulation during Development, Homeostasis and Alzheimer’s Disease
Casali, B. T., & Reed-Geaghan, E. G. (2021) · Cells · doi:10.3390/cells10040957 · Cited by 78
Gut inflammation associated with age and Alzheimer’s disease pathology: a human cohort study
Heston, M. B., Hanslik, K. L., Zarbock, K. R., Harding, S. J., Davenport‐Sis, N. J., Kerby, R. L., Chin, N. A., Sun, Y., Hoeft, A., Deming, Y. K., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-45929-z · Cited by 73
“or mitigate deposition of pathogenic Ab and pTau, depending on disease stage (26, 27).”
BackgroundSelf-citationGreen, T. R. F., Ortiz, J. B., Wonnacott, S., Williams, R. J., & Rowe, R. K. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00894 · Cited by 71
“, 2018) (see Figure 2; further discussed in section “TBI as a Contributor to AD”), where their likely/presumed function is to reduce neuronal exposure to soluble amyloid β-mediated toxicity (Wang et al., 2016).”
BackgroundXu, Y., Au, N. P. B., & Ma, C. H. E. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.896852 · Cited by 70
“…role in mediating the microglial phagocytic processes and cytokine production (Konishi and Kiyama, 2018), and the formation of TREM2-DAP12 complex is required for microglial activation to limit the accumulation and diffusion of Aβ plaques (Wang et al., 2015b, 2016; Yuan et al., 2016a).”
BackgroundHoeijmakers, L., Lesuis, S. L., Krugers, H. J., Lucassen, P. J., & Kőrösi, A. (2018) · Neurobiology of Stress · doi:10.1016/j.ynstr.2018.02.003 · Cited by 71
Manji, Z., Rojas, A., Wang, W., Dingledine, R., Varvel, N. H., & Ganesh, T. (2019) · Journal of Alzheimer’s Disease · doi:10.3233/jad-180678 · Cited by 60
“However, more recent studies in a parabiosis model have failed to identify blood-borne immune cells surrounding Aβ deposits, arguing that innate immune cells clustering around Aβ deposits are derived from the brain resident microglial population [60].”
Targeting Microglia-Synapse Interactions in Alzheimer’s Disease
Piccioni, G., Mango, D., Saidi, A., Corbo, M., & Nisticò, R. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22052342 · Cited by 63
Single-Cell RNA-Sequencing: Astrocyte and Microglial Heterogeneity in Health and Disease
Spurgat, M. S., & Tang, S. (2022) · Cells · doi:10.3390/cells11132021 · Cited by 69
“Interestingly, recent studies have revealed that microglia aggregate near amyloid-beta plaques in the brain and potentiate disease severity [38,39].”
BackgroundWang, M., Tang, G., Zhou, C., Guo, H., Hu, Z., Hu, Q., & Li, G. (2023) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2023.110387 · Cited by 66
Exercise mimetics: a novel strategy to combat neuroinflammation and Alzheimer’s disease
Zhao, R. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-024-03031-9 · Cited by 66
“They can prevent the spread and seeding of amyloid plaques, but this may also increase the neurotoxicity of the plaques [128].”
BackgroundHall-Roberts, H., Agarwal, D., Obst, J., Smith, T. B., Monzón-Sandoval, J., Di Daniel, E., Webber, C., James, W. S., Mead, E., Davis, J. B., et al. (2020) · Alzheimer's Research & Therapy · doi:10.1186/s13195-020-00709-z · Cited by 62
“TREM2 signalling ultimately regulates many major microglial functions, including phagocytosis [6], chemotaxis [7], survival and proliferation [8, 9], autophagy [10], lipid metabolism [11], and proinflammatory cytokine production [12].”
BackgroundPan-SHIP1/2 inhibitors promote microglia effector functions essential for CNS homeostasis
Pedicone, C., Fernandes, S., Dungan, O. M., Dormann, S. M., Viernes, D. R., Adhikari, A. A., Choi, L. B., De Jong, E. P., Chisholm, J. D., & Kerr, W. G. (2020) · Journal of Cell Science · doi:10.1242/jcs.238030 · Cited by 61
Lipofuscin-like autofluorescence within microglia and its impact on studying microglial engulfment
Stillman, J. M., Lopes, F. M., Lin, J., Hu, K., Reich, D. S., & Schafer, D. P. (2023) · Nature Communications · doi:10.1038/s41467-023-42809-y · Cited by 69
Novel targets in Alzheimer’s disease: A special focus on microglia
Balducci, C., & Forloni, G. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.01.017 · Cited by 66
Microglia: Friend and foe in tauopathy
Odfalk, K. F., Bieniek, K. F., & Hopp, S. C. (2022) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2022.102306 · Cited by 60
Dhandapani, R., Neri, M., Bernhard, M., Brzak, I., Schweizer, T., Rudin, S., Joller, S., Berth, R., Kernen, J., Neuhaus, A., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110883 · Cited by 60
Li, Q. S., & Muynck, L. D. (2021) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2021.100227 · Cited by 76
Exploring the Impact of TREM2 in Tumor-Associated Macrophages
Khantakova, D., Brioschi, S., & Molgora, M. (2022) · Vaccines · doi:10.3390/vaccines10060943 · Cited by 75
“Conversely, Trem2-deficient microglia fail to cluster around amyloid plaques, thus resulting in impaired barrier function and increased neuronal damage [8,35,47,48].”
BackgroundQiu, Y., Shen, X., Ravid, O., Atrakchi, D., Rand, D., Wight, A. E., Kim, H.-J., Liraz-Zaltsman, S., Cooper, I., Schnaider Beeri, M., et al. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2218915120 · Cited by 61
“We then examined Aβ uptake by CD11c microglial subset using methoxy-X04 (Me-XO4) [which labels fibrillar Aβ (25, 26)] in 5XFAD and OPN-KO.”
InfluentialWilson, E. N., Wang, C., Swarovski, M. S., Zera, K. A., Ennerfelt, H. E., Wang, Q., Chaney, A. M., Gauba, E., Benitez, J. A. R., Guen, Y. L., et al. (2024) · Nature Neuroscience · doi:10.1038/s41593-024-01610-w · Cited by 65
Shukla, A. K., McIntyre, L. L., Marsh, S. E., Schneider, C. A., Hoover, E. M., Walsh, C. M., Lodoen, M. B., Blurton‐Jones, M., & Inlay, M. A. (2019) · Glia · doi:10.1002/glia.23575 · Cited by 60
“Moreover, a follow-up study from the same group and others showed that shielding the head during irradiation to reduce BBB disruption, or use of parabiosis resulted in little to no contribution of bone marrow-derived cells to the PAM population, despite robust bone marrow engraftment and donor peripheral immune cell r…”
BackgroundTREM2 Promotes Immune Evasion by Mycobacterium tuberculosis in Human Macrophages
Dabla, A., Liang, Y. C., Rajabalee, N., Irwin, C. L., Moonen, C. G. J., Willis, J. V., Berton, S., & Sun, J. (2022) · mBio · doi:10.1128/mbio.01456-22 · Cited by 62
“TREM2 is well characterized in neurodegenerative diseases (23) and has been shown to mediate diverse functions in microglia, such as phagocytosis (24), inflam-”
BackgroundTriggering receptor expressed on myeloid cells 2 (TREM2) regulates phagocytosis in glioblastoma
Peshoff, M., Gupta, P., Oberai, S., Trivedi, R., Katayama, H. G., Chakrapani, P., Dang, M., Migliozzi, S., Gumin, J., Kadri, D. B., et al. (2024) · Neuro-Oncology · doi:10.1093/neuonc/noad257 · Cited by 62
Metadata
- Authors
- Wang, Y., Ulland, T. K., Ulrich, J. D., Song, W., Tzaferis, J. A., Hole, J. T., Yuan, P., Mahan, T. E., Shi, Y., Gilfillan, S., Cella, M., Grutzendler, J., DeMattos, R. B., Cirrito, J. R., Holtzman, D. M., & Colonna, M.
- Affiliations
- Eli Lilly (United States) (US)
- Washington University in St. Louis (US)
- Yale University (US)
- Corresponding author
- Colonna, Marco
- ORCID
- Venue
- Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2016-04-18
- Volume
- 213
- Issue
- 5
- Pages
- 667-675
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC4854736
- OpenAlex
- W2339534121
- Cited by
- 840
- References
- 32
- Citations by year
- 2026: 62 · 2025: 76 · 2024: 86 · 2023: 106 · 2022: 114 · 2021: 102 · 2020: 93 · 2019: 73 · 2018: 61 · 2017: 50 · 2016: 16
- FWCI
- 36.27
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Experimental Medicine (publishedVersion)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- Digital Commons@Becker (Washington University School of Medicine) (submittedVersion)
- Funders
- Eli Lilly and Company
- National Institutes of Health (RF1 AG05148501, 5T32CA009547-30, AG047644)
- National Multiple Sclerosis Society (RG4687A1/1)
- Cure Alzheimer’s Fund
- JPB Foundation
- Knight Alzheimer’s Disease Research Center (P50 AG005681-30)
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Keywords
- TREM2, microglia, amyloid plaques, Alzheimer's disease, parabiosis, 5xFAD mice, TREM2 deficiency, lipid microenvironment, peripheral blood monocytes
- MeSH terms
- Alzheimer Disease, Animals, Disease Models, Animal, Humans, Membrane Glycoproteins, Monocytes, Receptors, Immunologic, Amyloid beta-Peptides, Neurites, Microglia, Mice, Knockout, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.